GlassScriptPhysician profile
Sarunas Skirk
NPI 1154389849
$4,411.21
in general payments reported to CMS, 2019-2025
43 companies · $1,453 in 2025
The $1,453 reported for 2025 was more than what 93% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $241 · 2021: $21.49 · 2022: $431 · 2023: $331 · 2024: $860 · 2025: $1,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,563 · Education: $81.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,562.70 |
| Education | $81.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $346.23 | 2019-2025 | Briviact, Nayzilam |
| Biohaven Pharmaceutical Holding Company LTD. | $325.08 | 2022 | |
| Eisai INC. | $323.96 | 2019-2025 | |
| Lilly USA, LLC | $322.16 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Abbvie INC. | $281.47 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $266.34 | 2019-2025 | Nuplazid |
| Teva Pharmaceuticals USA, INC. | $257.89 | 2024-2025 | Austedo Xr, Austedo Xr |
| Alexion Pharmaceuticals, INC. | $243.75 | 2019-2025 | Ultomiris |
| Sk Life Science, INC. | $227.88 | 2023-2025 | Xcopri |
| Amneal Pharmaceuticals LLC | $157.59 | 2019-2025 | Crexont, Rytary |
| Emd Serono, INC. | $157.44 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $122.31 | 2019 | |
| Amgen INC. | $119.20 | 2019-2025 | Uplizna |
| Lundbeck LLC | $111.73 | 2020-2024 | Vyepti |
| Pfizer INC. | $95.92 | 2025 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarunas Skirk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.